As of 2026-03-08, the EV/EBITDA ratio of Bionano Genomics Inc (BNGO) is -0.41. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Bionano's latest enterprise value is 12.08 mil USD. Bionano's TTM EBITDA according to its financial statements is -29.68 mil USD. Dividing these 2 quantities gives us the above Bionano EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 12.4x - 14.5x | 13.2x |
| Forward P/E multiples | 17.2x - 22.1x | 19.8x |
| Fair Price | (50.16) - (42.47) | (48.11) |
| Upside | -4578.9% - -3891.6% | -4395.4% |
| Date | EV/EBITDA |
| 2026-03-06 | -0.41 |
| 2026-03-05 | -0.41 |
| 2026-03-04 | -0.42 |
| 2026-03-03 | -0.41 |
| 2026-03-02 | -0.41 |
| 2026-02-27 | -0.42 |
| 2026-02-26 | -0.42 |
| 2026-02-25 | -0.42 |
| 2026-02-24 | -0.41 |
| 2026-02-23 | -0.41 |
| 2026-02-20 | -0.41 |
| 2026-02-19 | -0.42 |
| 2026-02-18 | -0.41 |
| 2026-02-17 | -0.40 |
| 2026-02-13 | -0.40 |
| 2026-02-12 | -0.40 |
| 2026-02-11 | -0.41 |
| 2026-02-10 | -0.42 |
| 2026-02-09 | -0.42 |
| 2026-02-06 | -0.42 |
| 2026-02-05 | -0.41 |
| 2026-02-04 | -0.43 |
| 2026-02-03 | -0.43 |
| 2026-02-02 | -0.46 |
| 2026-01-30 | -0.47 |
| 2026-01-29 | -0.53 |
| 2026-01-28 | -0.54 |
| 2026-01-27 | -0.55 |
| 2026-01-26 | -0.55 |
| 2026-01-23 | -0.58 |
| 2026-01-22 | -0.60 |
| 2026-01-21 | -0.56 |
| 2026-01-20 | -0.52 |
| 2026-01-16 | -0.54 |
| 2026-01-15 | -0.54 |
| 2026-01-14 | -0.55 |
| 2026-01-13 | -0.56 |
| 2026-01-12 | -0.57 |
| 2026-01-09 | -0.56 |
| 2026-01-08 | -0.57 |
| 2026-01-07 | -0.57 |
| 2026-01-06 | -0.58 |
| 2026-01-05 | -0.57 |
| 2026-01-02 | -0.57 |
| 2025-12-31 | -0.55 |
| 2025-12-30 | -0.54 |
| 2025-12-29 | -0.53 |
| 2025-12-26 | -0.54 |
| 2025-12-24 | -0.54 |
| 2025-12-23 | -0.55 |